Fresenius Medical Care AG & Co. KGaA (ETR:FME) has been given a €85.00 ($100.00) price target by investment analysts at Deutsche Bank AG in a research note issued to investors on Monday, July 24th. The brokerage currently has a “neutral” rating on the stock.

FME has been the subject of several other reports. Morgan Stanley set a €90.00 ($105.88) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research note on Friday, May 5th. J P Morgan Chase & Co set a €104.50 ($122.94) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research note on Thursday, May 4th. Oddo Securities set a €95.00 ($111.76) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research note on Monday, June 12th. Kepler Capital Markets set a €95.00 ($111.76) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research note on Wednesday, May 3rd. Finally, S&P Global set a €95.00 ($111.76) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research note on Friday, June 9th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and ten have issued a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of €88.21 ($103.78).

Fresenius Medical Care AG & Co. KGaA (ETR:FME) traded down 0.65% during midday trading on Monday, hitting €79.18. 316 shares of the stock were exchanged. The stock has a market cap of €24.30 billion and a price-to-earnings ratio of 20.42. Fresenius Medical Care AG & Co. KGaA has a 52 week low of €70.82 and a 52 week high of €89.07. The firm’s 50-day moving average is €81.50 and its 200 day moving average is €81.20.

ILLEGAL ACTIVITY WARNING: This piece of content was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece of content on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/08/19/deutsche-bank-ag-reiterates-85-00-price-target-for-fresenius-medical-care-ag-co-kgaa-etrfme-updated-updated-updated.html.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Stock Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related stocks with our FREE daily email newsletter.